If you are:
Only When Necessary: ONLY AVAILABLE IN COMBINATION PRODUCTS THAT ARE ASSIGNED FDA CATEGORY C.
Precaution: INSUFFICIENT DATA AVAILABLE.
An adult over 60:
management or monitoring precaution: Neuro/Psych-Anticholinergic effects may cause sedation, worsen cognitive impairment and increase fall risk. Gastrointestinal-May cause or worsen pre-existing constipation. Genitourinary-Best avoided in patients with urinary retention from any cause.
Giving thonzylamine-chlophedianol Drops to a child under 12:
Contraindication: Risk of CNS effects. Not recommended age < 6 years unless clinician consult.
Contraindication: Possible CNS excitation, convulsions in newborns. Not recommended age <2 years.